Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Oncoimmunology|July 4, 2012
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cellsAndreas A Hombach, Johannes Heiders, Marcel Foppe, et al.Frontiers in Immunology|July 5, 2022
Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene EditingDimitrios L Wagner, Ulrike Koehl, Markus Chmielewski, et al.Scientific Reports|June 12, 2019
FimH-based display of functional eukaryotic proteins on bacteria surfacesMarkus Chmielewski, Johannes Kuehle, Danuta Chrobok, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2021
IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumorsAndreas Hombach, Markus Barden, Lisa Hannappel, et al.Frontiers in Immunology|September 29, 2017
Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of AsthmaJelena Skuljec, Markus Chmielewski, Christine Happle, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2016
Superior Therapeutic Index in Lymphoma Therapy: CD30(+) CD34(+) Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell AttackAndreas A Hombach, André Görgens, Markus Chmielewski, et al.Gastroenterology|July 24, 2012
Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in miceAmit Maliar, Charlotte Servais, Tova Waks, et al.Gastroenterology|July 4, 2012
T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in miceMarkus Chmielewski, Olga Hahn, Gunter Rappl, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2015
Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor ActivityMaarten A Ligtenberg, Dimitrios Mougiakakos, Madhura Mukhopadhyay, et al.Proceedings of the National Academy of Sciences of the United States of America|November 7, 2008
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasAnna Kruschinski, Andreas Moosmann, Isabel Poschke, et al.Pageof 4